NCT06611306View on ClinicalTrials.gov

BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.

NANot yet recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Brain Metastases, AdultBreast Cancer
Interventions
RADIATION

DE-iPTV

Dose-escalated VMAT-based radiotherapy, as previously described in our planning study

Trial Locations (1)

SW7 2AZ

Imperial College London, London

All Listed Sponsors
collaborator

University of Leicester

OTHER

collaborator

Centro Nacional de Investigaciones Oncologicas CARLOS III

OTHER

collaborator

East and North Hertfordshire NHS Trust

OTHER_GOV

collaborator

Norfolk and Norwich University Hospitals NHS Foundation Trust

OTHER

collaborator

Imperial College Healthcare NHS Trust

OTHER

lead

Imperial College London

OTHER

NCT06611306 - BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy. | Biotech Hunter | Biotech Hunter